Serum brain-derived neurotrophic factor, vascular endothelial growth factor and leptin levels in patients with a diagnosis of severe major depressive disorder with melancholic features
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Objective: Brain-derived neurotrophic factor (BDNF), vascular endothelial growth factor (VEGF) and leptin have been hypothesized to be involved in the neurobiology of depression. The aim of this study was to investigate BDNF, VEGF and leptin levels in patients with severe melancholic depression. Methods: A total of 40 drug-free patients with major depressive disorder (MDD) with melancholic features and 40 healthy controls were included in the study. Demographic information, psychiatric evaluation and physical examination were documented for both groups. Serum BDNF, VEGF levels were determined by enzyme-linked immunosorbent assay and leptin with radioimmunoassay methods. The Hamilton Depression Rating Scale and Hamilton Anxiety Rating Scale were applied to the patients. Results: There were no significant differences in serum BDNF, VEGF and leptin levels between the patient and control groups. There was a negative correlation between BDNF levels and the number of depressive episodes. It was noted that VEGF levels decreased with increasing severity of depression. Conclusions: These findings suggest that BDNF levels might be associated with the recurrence of depression and VEGF levels might be a determinant of the severity of depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transport of brain-derived neurotrophic factor across the blood–brain barrier
Pan, W., Banks, W. A., Fasold, M. B., Bluth, J., & Kastin, A. J. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00141-5 · Cited by 1,354
Gold, P. W., & Chrousos, G. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001032 · Cited by 1,274
Decreased serum brain-derived neurotrophic factor levels in major depressed patients
Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G., & Aubry, J.-M. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00005-7 · Cited by 1,232 · cited 4×
“Data about serum BDNF concentrations in major depression are conflicting, some authors reported levels as decreased [Karege et al. 2002, 2005; Shimizu et al. 2003; Aydemir et al. 2006; Monteleone et al. 2008], and others as unchanged [Ziegenhorn et al. 2007], compared with the healthy controls.”
BackgroundResultInfluentialShimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S.-I., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00181-1 · Cited by 1,151 · cited 4×
“Data about serum BDNF concentrations in major depression are conflicting, some authors reported levels as decreased [Karege et al. 2002, 2005; Shimizu et al. 2003; Aydemir et al. 2006; Monteleone et al. 2008], and others as unchanged [Ziegenhorn et al. 2007], compared with the healthy controls.”
BackgroundResultInfluentialThe stress system in the human brain in depression and neurodegeneration
Swaab, D. F., Bao, A.-M., & Lucassen, P. J. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.003 · Cited by 984 · cited 2×
“com It is surprising that there was no significant difference between serum cortisol levels of patients and controls as approximately 50% of depressed patients exhibit dysregulation of the hypothalamic– pituitary–adrenal (HPA) axis, which results in sustained elevations in cortisol levels [Gold and Chrousos, 2002; Swa…”
BackgroundSaarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00349.2003 · Cited by 800
Role of neurotrophic factors in depression
CASTREN, E., VOIKAR, V, & RANTAMAKI, T. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.009 · Cited by 667 · cited 1×
“Recently, the involvement of neurotrophic factors, particularly brain-derived neurotrophic factor (BDNF), have been under intense investigation regarding their possible role in the pathophysiology of mood disorders and its antidepressant effects [Castren et al. 2007].”
BackgroundPoduslo, J. F., & Curran, G. L. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00250-v · Cited by 614
Kendler, K. S., Thornton, L. M., & Gardner, C. O. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.4.582 · Cited by 480
Leptin: A potential novel antidepressant
Lu, X.-Y., Kim, C. S., Frazer, A., & Zhang, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508901103 · Cited by 446 · cited 2×
“On the basis of the finding of low circulating leptin levels in animal models of depression, it was hypothesized that leptin insufficiency may underlie depression-like behavioural deficits [Lu et al. 2006].”
Background
Cited by
Petra, A. I., Panagiotidou, S., Hatziagelaki, E., Stewart, J. M., Conti, P., & Theoharides, T. C. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.04.002 · Cited by 592
Nikkheslat, N., Zunszain, P. A., Horowitz, M. A., Barbosa, I. G., Parker, J. A., Myint, A.-M., Schwarz, M. J., Tylee, A. T., Carvalho, L. A., & Pariante, C. M. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.02.002 · Cited by 147
“…et al., 2010) levels in patients with MDD, others have found significant decreases in VEGF peripheral levels in depression (Dome et al., 2009; Isung et al., 2012; Katsuura et al., 2011) or no difference between patients with MDD and healthy controls (Kotan et al., 2012; Ventriglia et al., 2009).”
Sharma, A. N., da Costa e Silva, B. F. B., Soares, J. C., Carvalho, A. F., & Quevedo, J. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.067 · Cited by 142
“…Dome et al., 2009; Elfving et al., 2014; Fornaro et al., 2013; Galecki, Galecka, et al., 2013; Galecki, Orzechowska, et al., 2013; Iga et al., 2007; Kotan et al., 2012; Takebayashi et al., 2010; Tsai et al., 2009; Ventriglia et al., 2009; Viikki et al., 2010), and four assessed MDD and BD…”
InfluentialGrowth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders
Galvez-Contreras, A. Y., Campos-Ordonez, T., Lopez-Virgen, V., Gomez-Plascencia, J., Ramos-Zuniga, R., & Gonzalez-Perez, O. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.08.004 · Cited by 112
VEGF and depression: A comprehensive assessment of clinical data
Clark-Raymond, A., & Halaris, A. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.04.008 · Cited by 108
Metadata
- Authors
- Kotan, Z., Sarandöl, E., Kırhan, E., Özkaya, G., & Kırlı, S.
- Venue
- Therapeutic Advances in Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2012-02-09
- Volume
- 2
- Issue
- 2
- Pages
- 65-74
- ISSN
- 2045-1253 (ISSN-L)
- 2045-1261
- OpenAlex
- W2052343904
- Cited by
- 51
- References
- 18
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum brain-derived neurotrophic factor, vascular endothelial growth factor and leptin levels in patients with a diagnosis of severe major depressive disorder with melancholic features. https://app.cochat.ai/papers/10.1177/2045125312436572
- The paper
- Kotan, Z., Sarandöl, E., Kırhan, E., Özkaya, G., & Kırlı, S. (2012). Serum brain-derived neurotrophic factor, vascular endothelial growth factor and leptin levels in patients with a diagnosis of severe major depressive disorder with melancholic features. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125312436572
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.